These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 57444)

  • 1. Effect of "fractionated" insulins on total plasma insulin binding capacity and insulin requirements in severe diabetes.
    Oakley NW
    Lancet; 1976 May; 1(7967):994-6. PubMed ID: 57444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin binding capacity in patients changed from conventional to highly purified insulins. An indicator of likely response.
    Mustaffa BE; Daggett PR; Nabarro JD
    Diabetologia; 1977 Aug; 13(4):311-5. PubMed ID: 562300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of insulin antibodies on insulin dose and diabetic control.
    Walford S; Allison SP; Reeves WG
    Diabetologia; 1982 Feb; 22(2):106-10. PubMed ID: 7037511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin.
    Asplin CM; Hartog M; Goldie DJ
    Diabetologia; 1978 Feb; 14(2):99-105. PubMed ID: 631462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Highly purified insulins.
    Devlin JG; Parameswaran V
    Lancet; 1976 Jun; 1(7973):1355. PubMed ID: 58350
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunogenicity of new insulins.
    Deckert T
    Diabetes; 1985 Jun; 34 Suppl 2():94-6. PubMed ID: 3888748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins.
    Gray RS; Borsey DQ; Fraser DM; Kurtz AB; Rainbow S; Smith AF; Duncan LJ; Clarke BF
    Diabetologia; 1981 Sep; 21(3):206-10. PubMed ID: 7028552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin, insulin antibodies and insulin requirement in the first period of insulin treatment in non-insulin resistant diabetics.
    Lev-Ran A; Ratt L; Gersht N
    Acta Diabetol Lat; 1975; 12(1):66-71. PubMed ID: 1229807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical comparison of purified bovine and purified porcine insulins.
    Olczak SA; Greenwood RH
    Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial with porcine des-Phe B1 insulin. A comparative study with unmodified insulin on therapeutical efficacy, biological activity and immunogenicity.
    Santeusanio F; Massi-Benedetti M; Clementi A; Calabrese G; Bueti A; Picchio E; Brunetti P
    Diabete Metab; 1981 Sep; 7(3):173-9. PubMed ID: 7033008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical use of NPH insulin (author's transl)].
    Roesner M; Sauer H
    Dtsch Med Wochenschr; 1976 Jun; 101(23):886-9. PubMed ID: 1269430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate-acting insulin preparations: NPH and lente.
    Deckert T
    Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twice-daily insulin regimens in management of severe diabetes.
    Oakley N; Mather H; Hadley L; Lynch J; Pilkington T
    J R Soc Med; 1981 May; 74(5):363-7. PubMed ID: 7017138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new insulins. Their characteristics and clinical indications.
    Home PD; Alberti KG
    Drugs; 1982 Nov; 24(5):401-13. PubMed ID: 6756879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of soluble porcine and human insulin (Novo) using the artificial pancreas.
    Mirouze J; Benghernaout O; Pham TC; Richard JL; Bringer J
    Diabetes Care; 1983; 6 Suppl 1():40-2. PubMed ID: 6343037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of injection techniques for soluble and protamine zinc insulins in diabetes mellitus.
    Harrower AD; Duncan LJ; Clarke BF
    Practitioner; 1975 Feb; 214(1280):228-31. PubMed ID: 1144249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of highly purified porcine and human insulins in diabetic patients with high titers of insulin antibody.
    Lam HC; Ho LT; Tang KT; Wang LM; Kwok CF; Liu YF; Hsiao LJ; Li SH
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):346-51. PubMed ID: 2677227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-action characteristics of regular and NPH insulin in insulin-treated diabetics.
    Roy B; Chou MC; Field JB
    J Clin Endocrinol Metab; 1980 Mar; 50(3):475-9. PubMed ID: 6987253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential response to infusions of highly purified and conventional bovine and porcine insulins.
    Nosadini R; Noy G; Kurtz AB; Alberti KG
    Diabetes; 1981 Aug; 30(8):650-5. PubMed ID: 7018969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.